Transcription of DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
Example: marketing
DATA SHEET - Medsafe
viread data SHEET (14 July 2017) 1 of 46 data SHEET 1. viread ( TENOFOVIR DISOPROXIL FUMARATE 300 mg) TABLETS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Tenofovir disoproxil fumarate 300 mg For full list of excipients, see section 3. PHARMACEUTICAL FORM Film-coated tablet. viread tablets are light blue and almond-shaped. Each tablet is debossed on one side with the markings GILEAD and 4331 and on the other side with the marking 300 . 4. CLINICAL PARTICULARS Therapeutic Indications viread in combination with other antiretroviral agents is indicated for the treatment of HIV-infected adults and paediatric patients 12 years of age and older. viread is indicated for the treatment of chronic hepatitis B in adults and in paediatric patients 12 years of age and older. Dose and method of administration Adults: The recommended dose is 300 mg (one tablet) once daily taken orally with or without food.
VIREAD Data Sheet (14 July 2017) 2 of 46 illnesses or the need for treatment with other medicinal products concomitantly with VIREAD should be taken into consideration.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: